Letrozol Omet Pharma (Letrozole)

Letrozole works by selectively blocking the aromatase enzyme, which converts androgens into estrogens in peripheral tissues. This inhibition leads to a marked reduction in circulating estrogen levels, depriving estrogen‑dependent cancer cells of the hormone stimulus needed for their proliferation.

The specific dose of Letrozol Omet Pharma is determined by the prescribing clinician based on the patient’s clinical condition, treatment stage, and individual factors. Healthcare professionals follow approved dosing guidelines and adjust as needed for safety and efficacy.

Letrozole is classified as contraindicated in pregnancy because it can interfere with fetal development. Women of child‑bearing potential should use effective contraception during treatment. Safety during breastfeeding has not been established, and breastfeeding is generally not recommended while on letrozole.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Letrozole, anastrozole and exemestane are the three main aromatase inhibitors used in postmenopausal breast cancer. Letrozole generally provides slightly higher estrogen suppression, which can translate into marginally better disease‑free survival in some studies, while anastrozole is often preferred for its once‑daily dosing and exemestane for its steroidal structure. Choice depends on physician judgment, patient tolerance and specific clinical scenarios.

Store Letrozol Omet Pharma at temperatures below 25 °C in its original container, protecting it from moisture, direct sunlight and excessive heat. Keep the tablet blister pack sealed until use and avoid exposing the product to humidity to maintain potency.

Letrozol Omet Pharma is taken orally, usually as a whole tablet swallowed with water. It is typically taken once daily, at the same time each day, with or without food, as directed by the prescribing healthcare professional.

Serious adverse events include severe liver injury, bone fractures due to decreased bone mineral density, pulmonary embolism, and severe allergic reactions such as anaphylaxis. Patients should be monitored regularly for signs of these conditions, and treatment should be stopped if any serious reaction occurs.

Letrozol Omet Pharma should not be used in premenopausal women, pregnant or breastfeeding individuals, patients with known hypersensitivity to letrozole, or those with severe hepatic impairment. Clinicians must assess each patient’s medical history before initiating therapy.